WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

Objective: Patients with cancer are considered highly vulnerable to the COVID-19 disease. However, there are still few data in hematologic patients. Some small studies have shown a high mortality on patients with hematologic malignancies and COVID-19. In this study we aim to report a single center e...

Full description

Bibliographic Details
Main Authors: Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, Mustafa Nuri YENEREL, Meliha NALCACI, Sevgi KALAYOGLU BESISIK, Sevda SERT EKINCI, Tufan TUKEK
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Hematology, Transfusion and Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137921012104

Internet

http://www.sciencedirect.com/science/article/pii/S2531137921012104

Similar Items